Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2002
11/07/2002WO2002087572A1 Triazole derivative solution preparations
11/07/2002WO2002087570A1 Composition comprising antifungal agents for treating vulvovaginitis and vaginosis
11/07/2002WO2002087564A1 Class of glaucoma drugs to enhance aqueous humor outflow and lower intra-ocular pressure
11/07/2002WO2002087563A2 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
11/07/2002WO2002087558A1 Pharmaceutical composition which reduces or eliminates drug abuse potential
11/07/2002WO2002087550A1 Tablets with coloured patterns and preparation thereof
11/07/2002WO2002087549A1 Multiple unit type sustained-release tablets
11/07/2002WO2002087548A1 A pharmaceutical tablet having a high api content
11/07/2002WO2002087547A1 An improved process for preparation of four-drug anti-tubercular fixed dose combination
11/07/2002WO2002087546A2 Method for manufacturing a low dose pharmaceutical composition
11/07/2002WO2002087545A1 Composition and methods for treatment of hyperplasia
11/07/2002WO2002087544A1 Flavored product containing medicament or other active agent
11/07/2002WO2002087543A1 Sustained release formulations for nifedipine, dextromethorphan, and danazol
11/07/2002WO2002087542A1 Novel methods and compositions for delivering macromolecules to or via the respiratory tract
11/07/2002WO2002087541A1 Lipid-based formulations for gene transfer
11/07/2002WO2002087540A1 Artificial blood made of hemoglobin encapsulated in liposomes
11/07/2002WO2002087512A2 Once-a-day oxycodone formulations
11/07/2002WO2002087509A2 Colloidal metal compositions and methods
11/07/2002WO2002087497A2 Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use
11/07/2002WO2002087494A2 Novel vaccine
11/07/2002WO2002087482A1 Abuse resistant opioid containing transdermal systems
11/07/2002WO2002087481A1 Prevention of myocardial infarction induced ventricular expansion and remodeling
11/07/2002WO2002087424A2 Treatment and diagnosis of macrophage mediated disease
11/07/2002WO2002087338A1 Liquid formulations for dermal application in treatment of parasitic insects in animals
11/07/2002WO2002087326A1 Compositions including vitamin-based surfactants ad methods for using same
11/07/2002WO2002078601A8 Drug release from polymer matrices through mechanical stimulation
11/07/2002WO2002067955A3 A process for the manufacture of a herbal composition comprising a matrine
11/07/2002WO2002066026A3 Tramadol-based medicament
11/07/2002WO2002056913A3 Stabilized brivudine topical formulations containing metal oxide pigments
11/07/2002WO2002055023A3 Therapeutic film forming composition and treatment system
11/07/2002WO2002051421A3 Gel composition and trans-scrotal application of a composition for the treatment of hypogonadism
11/07/2002WO2002047693A3 Steroid hormone products comprising a stabilizing agent in non-crystalline form
11/07/2002WO2002045681A3 Solid polyunsaturated fatty acid compositions
11/07/2002WO2002043580A3 Production of microspheres
11/07/2002WO2002041848A3 Propellant-gas-free spray preparations
11/07/2002WO2002040001A3 Compositions for treatment of malignant effusions comprising a biocompatible polymer and antineoplastic taxane
11/07/2002WO2002038135A3 Flexible barrier film for a support material for medical applications
11/07/2002WO2002038132A3 Soft capsules comprising a starch mixture having a reduced branching degree
11/07/2002WO2002028424A3 Kyberdrug as autovaccines with immune-regulating effects
11/07/2002WO2002024203A3 Controlled release formulations for oral administration
11/07/2002WO2002009767A3 Therapeutic polyanhydride compounds for drug delivery
11/07/2002WO2002009667A3 Dispersions for formulating slightly or poorly soluble active ingredients
11/07/2002WO2001015745A9 Method and formula for tumor remission and suppression of cancer
11/07/2002WO2001001929A3 Microcapsules iv
11/07/2002US20020165522 Method for use in cataract surgery
11/07/2002US20020165487 Substance delivery device
11/07/2002US20020165429 Clitoral sensitizing arrangements
11/07/2002US20020165406 Methods of synthesizing acylanilides including bicalutamide and derivatives thereof
11/07/2002US20020165361 Antibody for use in the diagnosis and treatment of cell proliferation disorders
11/07/2002US20020165359 Gelatin for use in the generation of films on capsules
11/07/2002US20020165315 Preparing aqueous polymer dispersions
11/07/2002US20020165287 Composition based on alkyl polyglycosides and fatty alcohols, and its uses
11/07/2002US20020165286 Lipophilic excipient capable of dissolving the drug, targeting to the pilosebaceous ducts on the skin; antiacne
11/07/2002US20020165285 Production of dry powders of one or more oxygenated carotenoids
11/07/2002US20020165265 Microtubule disrupter such as paclitaxel, and a polymeric carrier that is NOT a capsule; embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions
11/07/2002US20020165254 Autoclavable pharmaceutical compositions containing a chelating agent
11/07/2002US20020165249 Nasal delivery of apomorphine
11/07/2002US20020165248 Opiod analgesic
11/07/2002US20020165244 Mucin synthesis inhibitors
11/07/2002US20020165220 Topical dispersion; water solutions; evaporation
11/07/2002US20020165211 Aqueous suspension of Fluticasone furoate; respiratory tract disorders; asthma, COPD; antiinflammatory, antiallergen; nasal inhaler
11/07/2002US20020165209 Low dose estrogen interrupted hormone replacement therapy
11/07/2002US20020165164 New effectors of dipeptidyl peptidase IV for topical use
11/07/2002US20020165134 Emulsion preconcentrates; triglyceride mixture
11/07/2002US20020165122 Method and compositions for the treatment or amelioration of female sexual dysfunction
11/07/2002US20020165121 Topical application for treating toenail fungus
11/07/2002US20020164758 Enzymatic polypeptide for use in the diagnosis and treatment of allergies, heart and respiratory disorders
11/07/2002US20020164681 Gelatins with improved gliding power, processes for their preparation and their applications
11/07/2002US20020164557 Characterization of an antibiotic impregnated delivery system as an intracanal medicament in endodontic therapy
11/07/2002US20020164482 Nanotechnology for biomedical products
11/07/2002US20020164398 Chewing gums core with coating; drug delivery
11/07/2002US20020164381 Mixture containing sulfur and sulfur compound
11/07/2002US20020164380 Vitamin e, solvent and alumina
11/07/2002US20020164379 Oxygen-containing ophthalmic composition
11/07/2002US20020164377 Mixture of retinoic acid and paclitaxel; polymeric carrier
11/07/2002US20020164376 Microparticles and their use in cancer treatment
11/07/2002US20020164374 Biodegradation insert; mixture of drug and polymer
11/07/2002US20020164373 Opioid sustained-released formulation
11/07/2002US20020164372 Controlled release systems for polymers
11/07/2002US20020164371 For tablets; compression blend; sustained release
11/07/2002US20020164370 Simple compression
11/07/2002US20020164369 Novel soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
11/07/2002US20020164368 Oral administering; mixture containing cationic salt
11/07/2002US20020164367 Mixture of oleanolic acid and polysaccharides
11/07/2002US20020164366 Transdermal delivery system
11/07/2002US20020164365 Multifaceted compositions for post-surgical adhesion prevention
11/07/2002US20020164362 Cosmetic product containing shellac
11/07/2002US20020164359 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
11/07/2002US20020164357 Lipopolysaccharides from gramnegative bacteria
11/07/2002US20020164338 Combined approach to treatment of cancer with hCG vaccines
11/07/2002US20020164290 Biocompatible compounds for sustained release pharmaceutical drug delivery systems
11/07/2002US20020164267 Preventing immunologically mediated beta cell failure prior to or after the onset of Type 2 diabetes with inhaled insulin, by administering to a human patient in need of such prevention, an effective amount of inhaled insulin
11/07/2002US20020162791 Method for fabricating three dimensional structures
11/07/2002DE10121471A1 Plaster for controlled release of active agent to skin or wounds, comprising adsorbent, pressure-sensitive adhesive matrix surface-doped with active agent, e.g. dexpanthenol
11/07/2002DE10120092A1 Magensaftresistente Vorrichtung zur Freisetzung von mukoadhäsiven Wirkstoffträgern und Verfahren zur Herstellung der magensaftresistenten Vorrichtung Gastro-resistant device for releasing of mucoadhesive drug carriers and procedures for preparing the enteric device
11/07/2002DE10109897A1 Fakultativ kationische Liposomen und Verwendung dieser Optional cationic liposomes and use of these
11/07/2002DE10061135C1 Stable gel preparation for oral administration of acid-labile drug, especially proton pump inhibitor, comprises multiple drug units dispersed in gel base
11/07/2002CA2821193A1 Prevention of myocardial infarction induced ventricular expansion and remodeling
11/07/2002CA2747159A1 Biodegradable elastomer and method of preparing same
11/07/2002CA2601222A1 Once-a-day oxycodone formulations
1 ... 2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 ... 2991